Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 13, 2013 - Issue 2: Monoclonal Antibodies
Submit an article Journal homepage
825
Views
18
CrossRef citations to date
0
Altmetric
Reviews

Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia

Preetesh JainDepartment of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, [email protected]
, MD DM PhD &
Susan O'BrienDepartment of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, [email protected]
, MD
Pages 169-182 | Published online: 21 Dec 2012

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Reza Maleki, Azam Rahimpour & Masoumeh Rajabibazl. (2023) Construction and evaluation of wild and mutant ofatumumab scFvs against the human CD20 antigen. Preparative Biochemistry & Biotechnology 53:3, pages 239-246.
Read now
Christian Klein, Alfred Lammens, Wolfgang Schäfer, Guy Georges, Manfred Schwaiger, Ekkehard Mössner, Karl-Peter Hopfner, Pablo Umaña & Gerhard Niederfellner. (2013) Response to: Monoclonal antibodies targeting CD20. mAbs 5:3, pages 337-338.
Read now

Articles from other publishers (16)

Robert C. BastJrJr & Michael R. Zalutsky. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 31 .
Zahra Payandeh, Armina Alagheband Bahrami, Reyhaneh Hoseinpoor, Yousef Mortazavi, Masoumeh Rajabibazl, Azam Rahimpour, Amir Hossein Taromchi & Saeed Khalil. (2019) The applications of anti-CD20 antibodies to treat various B cells disorders. Biomedicine & Pharmacotherapy 109, pages 2415-2426.
Crossref
Andrea Angioi, Nicola Lepori, Ana Coloma López, Sanjeev Sethi, Fernando C. Fervenza & Antonello Pani. (2017) Treatment of primary membranous nephropathy: where are we now?. Journal of Nephrology 31:4, pages 489-502.
Crossref
Piero Ruggenenti, Fernando C. Fervenza & Giuseppe Remuzzi. (2017) Treatment of membranous nephropathy: time for a paradigm shift. Nature Reviews Nephrology 13:9, pages 563-579.
Crossref
Robert C. BastJr.Jr., Michael R. Zalutsky & Arthur E. Frankel. 2016. Holland-Frei Cancer Medicine. Holland-Frei Cancer Medicine 1 23 .
Soubhagya Laxmi Sahoo, Chi-Hsien Liu & Wei-Chi Wu. (2017) Lymphoma cell isolation using multifunctional magnetic nanoparticles: antibody conjugation and characterization. RSC Advances 7:36, pages 22468-22478.
Crossref
Alain Trautmann. (2016) From kinetics and cellular cooperations to cancer immunotherapies. Oncotarget 7:28, pages 44779-44789.
Crossref
Satoru Takanashi, Tomonori Nochi, Miku Abe, Nanami Itaya, Megumi Urakawa, Katsuyoshi Sato, Tao Zhuang, Saori Umemura, Tomohito Hayashi, Yoshio Kiku, Haruki Kitazawa, Michael T. Rose, Kouichi Watanabe & Hisashi Aso. (2015) Extracellular cyclophilin A possesses chemotaxic activity in cattle. Veterinary Research 46:1.
Crossref
Preetesh Jain & Susan O'Brien. 2015. Targeted Therapy in Translational Cancer Research. Targeted Therapy in Translational Cancer Research 130 144 .
Rui Zhang, Jiyuan Yang, Te-Wei Chu, Jonathan M. Hartley & Jind?ich Kope?ek. (2015) Multimodality Imaging of Coiled-Coil Mediated Self-Assembly in a ?Drug-Free? Therapeutic System. Advanced Healthcare Materials 4:7, pages 1054-1065.
Crossref
Paolo Cravedi, Giuseppe Remuzzi & Piero Ruggenenti. (2014) Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?. Nephron Clinical Practice 128:3-4, pages 261-269.
Crossref
Katarzyna Urbanska, Rachel C Lynn, Caitlin Stashwick, Archana Thakur, Lawrence G Lum & Daniel J Powell. (2014) Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells. Journal of Translational Medicine 12:1.
Crossref
Kim L Brunekreeft, Corinna Strohm, Marloes J Gooden, Anna A Rybczynska, Hans W Nijman, Götz U Grigoleit, Wijnand Helfrich, Edwin Bremer, Daniela Siegmund, Harald Wajant & Marco de Bruyn. (2014) Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death. Molecular Cancer 13:1.
Crossref
Ludmila Sebejova, Marek Borsky, Zuzana Jaskova, David Potesil, Veronika Navrkalova, Jitka Malcikova, Martin Sramek, Michael Doubek, Tomas Loja, Sarka Pospisilova, Jiri Mayer & Martin Trbusek. (2014) Distinct in vitro sensitivity of p53-mutated and ATM-mutated chronic lymphocytic leukemia cells to ofatumumab and rituximab. Experimental Hematology 42:10, pages 867-874.e1.
Crossref
Margaret A. Lindorfer, Joost M. Bakker, Paul W.H.I. Parren & Ronald P. Taylor. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 1733 1774 .
Jason A. DubovskyDanielle L. ChappellBonnie K. HarringtonKitty Agrawal, Leslie A. AndritsosJoseph M. FlynnJeffrey A. JonesMichael E. Paulaitis, Brad Bolon, Amy J. JohnsonJohn C. ByrdNatarajan Muthusamy. (2013) Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing. Blood 122:19, pages 3308-3316.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.